Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026)

Structure Therapeutics' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 8.87% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 8.87% decrease from a year earlier, with the FY2025 full-year figure at $717000.0, down 85.96% from the prior year.
• Other Non-Current Assets climbed to $5.6 million in Q1 2026 per GPCR's latest filing, from $717000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.6 million in Q3 2025 and bottomed at $38000.0 in Q2 2023.
• The 5-year median for Other Non-Current Assets is $1.8 million (2024), against an average of $2.7 million.
• Across the five-year window, Other Non-Current Assets plunged 98.7% in 2023 and surged 12870.21% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $3.5 million in 2022, then plunged by 98.7% to $45000.0 in 2023, then jumped by 11246.67% to $5.1 million in 2024, then tumbled by 85.96% to $717000.0 in 2025, then soared by 674.76% to $5.6 million in 2026.
• Per Business Quant, the three latest GPCR Other Non-Current Assets figures stand at $5.6 million (Q1 2026), $717000.0 (Q4 2025), and $6.6 million (Q3 2025).